AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.400
+0.300 (27.27%)
At close: Oct 16, 2025, 4:00 PM EDT
1.300
-0.100 (-7.14%)
Pre-market: Oct 17, 2025, 8:50 AM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
16.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | 2.52M | -839.00K | -24.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
AEON News
- 16 days ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 5 months ago - AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - GlobeNewsWire
- 5 months ago - AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
- 6 months ago - AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - GlobeNewsWire
- 7 months ago - AEON Biopharma Announces CEO Transition - GlobeNewsWire